MaxCyte scalable transient transfection enables high quality, biologically relevant cellular assays that can take assay development off the critical path. Requiring no specific constructs, engineered cells, specialized media, or reagent additives, MaxCyte electroporation offers a unique, cost-effective choice for rapid assay development and screening of a variety of receptors. In this webinar we will present real world data for cell-based assays in biologically relevant cells including complex transporter assays, sodium-gated ion channels, GPCRs and siRNA knockdown.

Learning Objectives:

  • Assay development from construct to HTS in as short as 2-3 days
  • Screening in biologically relevant cellular systems
  • Reduced reliance on stable cell lines
  • Bulk transfection and cryopreservation to produce assay-ready cells
  • Rapid method development and scale up
  • Transfection of 5E5 cells in seconds up to 2E11 cells in less than 30 minutes

Discussions lead by:

Jinliang Sui, MD, Ph.D.
Senior Director of HTS & Bioinformatics, Flatley Discovery Lab

James Brady, Ph.D.
Director, Technical Applications, MaxCyte, Inc.

Mark Schmeizl
VP, Global Sales, MaxCyte, Inc.

Learn about cutting-edge applications, new resources, and upcoming events.
Subscribe to our e-Newsletter

Sign Up